RODRIGO FALCAO: Open Payments
NPI 1023266426 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 92 payments from 14 companies in 2025. Trend: 2023 $33 · 2024 $1,940 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $207 |
| Supernus Pharmaceuticals, Inc. | 11 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $169 |
| ABBVIE INC. | 17 | $159 |
| Otsuka America Pharmaceutical, Inc. | 11 | $157 |
| Axsome Therapeutics, Inc. | 9 | $136 |
| Neurocrine BioSciences, Inc. | 6 | $132 |
| Lundbeck LLC | 5 | $118 |
| Alkermes, Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: REXULTI, Qelbree, SPRAVATO, CAPLYTA, VRAYLAR, Auvelity, INGREZZA, LYBALVI.
Industry payments across GA — which companies pay providers there.
